Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A box of Moderna Spikevax (COVID-19 Vaccine, mRNA) is kept in the refrigerator at Skippack Pharmacy in Schwenksville, ...

Sept 18 (Reuters) - Moderna (MRNA.O), opens new tab has settled related lawsuits that accused it of misusing Alnylam Pharmaceuticals' (ALNY.O), opens new tab patented technology in its COVID-19 ...

Add Yahoo as a preferred source to see more of our stories on Google. A nurse draws up doses of the Moderna COVID-19 for a vaccination clinic in St. Helena in 2021. Moderna is offering a new, low-dose ...

A patent dispute over technology key to messenger RNA Covid-19 vaccines is settling with Moderna agreeing to pay $950 million up front and potentially more than $1 billion later, a resolution that ...

A federal work group says Covid vaccine injuries deserve urgent attention, even as Health Secretary Robert F. Kennedy Jr.

A model of a new vaccine targeting a family of coronaviruses that includes the virus that causes COVID-19. The image highlights pieces of several different viruses attached to a computer-designed ...

A Moderna spokesperson said the company is aware of the lawsuit and will defend itself. Spokespeople for Pfizer, BioNTech and Johnson & Johnson did not immediately respond to requests for comment.

You may have seen ads for a new, lower-dose Moderna COVID vaccine marketed to "the senior class" - adults 65 and older. The new vaccine, which goes by mRNA-1283 or mNexspike, was approved by the U.S.